Kairos Pharma, Ltd. (KAPA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-7, first reflected in a filing dated 2026-11-13. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

18.43M
Year ended 2025-12-31
2023-12-31: 10.38M2024-12-31: 11.36M2025-12-31: 18.43M18.43M
2023-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3118.43M+62.3%2026-03-31, From 2025-01-01
2024-12-3111.36M+9.4%2026-03-31, From 2024-01-01
2023-12-3110.38Mn/a2025-04-15, From 2023-01-01